Fig. 2From: Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort studyOxygenation parameters pre-and 24-h post inhaled nitric oxide administrationBack to article page